Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Ara macao whole-genome sequencing

PROVIDER: PRJNA997712 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25548343_1.fastq.gz	Fastqsanger.gz
	SRR25548343_2.fastq.gz	Fastqsanger.gz
	SRR25548344_1.fastq.gz	Fastqsanger.gz
	SRR25548344_2.fastq.gz	Fastqsanger.gz
	SRR25548345_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

Ara macao

Project description:Ara macao

| PRJNA703524 | ENA

Ara macao

Project description:Ara macao overview

| PRJNA204946 | ENA

Ara macao

Project description:Ara macao Genome sequencing and assembly

| PRJNA175470 | ENA

Ara macao

Project description:Ara macao Genome sequencing and assembly

| PRJNA189648 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Ara glaucogularis

Project description:Ara glaucogularis Whole Genome Sequencing

| PRJNA642113 | ENA

Gene expression profiling during Ara-C induced NB4 cell apoptosis

Project description:As the most important antimetabolite used to induce remission in children and adults with acute leukemia, cytosine arabinoside (Ara-C) is widely used in consolidation therapy of APL to reduce the relapse rate. In order to better understand the molecular mechanism underlying Ara-C induced cell early apoptosis, we examined the mRNA level changes of NB4 cells after Ara-C treatment over the 12 h time course using a human whole genome oligo-array.

2011-10-15 | GSE32992 | GEO

Transcriptional profile of AML xenografts treated with either PBS or a combination of decitabine and cytarabine

Project description:The Affymetrix Human Genome U133 Plus 2.0 Array was used to examine the Genome wide transcriptional changes which follow the treatment of AML xenografts with either PBS control or combination of decitabine (DAC) and cytarabine (Ara-C). Animals were treated with PBS, DAC alone, Ara-C alone, DAC and Ara-C combined (D+A), DAC followed by Ara-C (D/A) or Ara-C followed by DAC (A/D).

2013-03-06 | GSE44857 | GEO

Treatment of AML patient samples with decitabine

Project description:Genome wide DNA methylation profiling of AML patient samples treated with PBS or DAC. The Illumina Infinium 450 Human DNA methylation was used to examine the methylation profile of 8 patient samples and 2 cell lines. Genome wide DNA methylation profiling of AML xenografts treated with either PBS control or with decitacine (DAC) alone, cytarabine (Ara-C) alone, DAC and Ara-C together (D+A), DAC followed by Ara-C (D/A) or with Ara-C followed by DAC (A/D).

2013-03-06 | GSE44830 | GEO

Gene expression profiling during Ara-C induced NB4 cell apoptosis

2011-10-14 | E-GEOD-32992 | biostudies-arrayexpress